Both sales were pre-planned under 10b5-1 arrangements and are trivial relative to market cap. Monitor the next 10-Q for any further deterioration in airway clearance revenue and operating expense trends, which were the key negatives in the Q3 report.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 10 $26.62entry
- T+1 · 6d ago +1.92%α +0.60% · $27.13
- T+4 · todayOpen
- T+5 · in 4h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two directors sold a combined $255K of TCMD stock under 10b5-1 plans within a week of Q3 earnings that missed consensus EPS and showed a net income decline. The sales represent 0.04% of market cap, well below the 0.1% materiality threshold, and are routine in size.
Key Financial Metrics
Key Facts
- Director William W. Burke sold 5,000 shares at $27.00 for $135K on 2026-11-04 under a 10b5-1 plan
- Director Laura G. King sold 4,800 shares at $25.00 for $120K on 2026-11-03 under a 10b5-1 plan
- Total open-market sales of $255K represent 0.04% of TCMD's $592M market cap
- Q3 2026 earnings filed 7 days prior: revenue $91.9M (+7% YoY), GAAP EPS $0.31 vs $0.34 consensus, net income declined to $7.2M from $8.2M
- COO Stephen A. Kiewiet received a non-cash grant of 6,438 shares on 2026-11-04 (no economic value)
Financial Impact
Total insider open-market sales of $255K, or 0.04% of market cap
Risk Factors
- Sales are 10b5-1 planned, reducing their informational value
- Q3 earnings showed net income decline and an EPS miss, but insider sales are too small to signal a material concern
- Airway clearance revenue fell 25% YoY due to DME inventory transition
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TCMD-1794268261995 |
Track record
17 reports on TCMD
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $26.99 Now $26.37 −2.30% settles Feb 12
- Nov 13, 20263d ago SC 13G Neutral 4/10 Entry $27.11 Now $26.37 −2.73% settles Feb 12
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Viewing Entry $26.62 Now $26.37 −0.94% settles Feb 8
- Nov 6, 202610d ago 3 Neutral 2/10 Entry $26.59 Now $26.37 −0.83% settles Feb 5
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $24.78 Now $26.37 +6.42% settles Feb 1
- Nov 2, 202614d ago 10-Q/A Neutral 2/10 Entry $24.78 Now $26.37 +6.42% settles Feb 1
- Nov 2, 202614d ago 10-Q/A Neutral 2/10 Entry $24.78 Now $26.37 +6.42% settles Feb 1
- Nov 2, 202614d ago Press Release Bearish 5/10 No price data
- Nov 2, 202614d ago 8-K Mixed 5/10 Entry $24.78 Now $26.37 +6.42% settles Feb 1
- Oct 19, 202628d ago Press Release Neutral 3/10 Entry $23.52 Now $26.37 +12.12% settles Jan 15
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers